| Quarter | Score |
|---|---|
| 2022-Q1 | 49.3 |
| 2022-Q3 | 41.0 |
| 2022-Q4 | 52.7 |
| 2023-Q2 | 63.8 |
| 2023-Q3 | 48.0 |
| 2023-Q4 | 65.6 |
| 2024-Q1 | 47.1 |
| 2024-Q2 | 53.3 |
| 2024-Q3 | 81.0 |
| 2024-Q4 | 79.5 |
| 2025-Q1 | 80.5 |
| 2025-Q2 | 80.3 |
| 2025-Q3 | 81.9 |
| 2025-Q4 | 83.5 |
| 2026-Q1 | 83.5 |
| 2026-Q2 | 83.4 |
Strong consensus, but price is extended — wait for pullback to funds' basis
Trading +32.4% above funds' purchase price — elevated pullback risk
2 of 18 tracked funds hold CB. Avg conviction: 2.0%. Net adding. First tracked at $271.74 (current +32.4% vs tracked).
Berkshire Hathaway has 3.9% in this stock
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Berkshire Hathaway | 3.9% | Hold |
| Citadel Advisors | 0.0% | Add |